4.6 Article

The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer

Journal

AMERICAN JOURNAL OF CANCER RESEARCH
Volume 11, Issue 4, Pages 1480-+

Publisher

E-CENTURY PUBLISHING CORP

Keywords

lncRNA; PVT1; endometrial cancer; miR-612; CENP-H; ceRNA; CDK1

Categories

Funding

  1. National Natural Science Foundation of China [81872123]
  2. University Innovation Team of Liaoning Province [2018-479]
  3. Major Special Construction Plan for Discipline Construction of China Medical University [3110118029]
  4. Liaoning Revitalization Talents Program [XLYC1902003]
  5. Outstanding Scientific Fund of Shengjing Hospital [201601]

Ask authors/readers for more resources

By constructing a PVT1-centered ceRNA network, this study revealed that the PVT1/miR-612/CENP-H/CDK1 axis plays a crucial role in promoting the malignant progression of advanced endometrial cancer, providing a potential therapeutic target.
Our previous study introduced the oncogenic role of the long non-coding RNA plasmacytoma variant trans location 1 (PVT1) in endometrial cancer (EC). In this study, we aimed to construct a PVT1-centered competing endogenous RNA (ceRNA) network to outline a regulatory axis that might promote the malignant progression of advanced EC. Raw Uterine Corpus Endometrial Carcinoma (UCEC) datasets were collected from The Cancer Genome Atlas (TCGA) database and used for construction of the PVT1-centered ceRNA network. The ceRNA binding sites were established using dual-luciferase assays. FISH assays displayed the co-location of PVT1 and miR-612 in EC cells. Immunohistochemistry, in situ hybridization, qRT-PCR, and western blots were used to assess the expression of miR-612 and CENP-H in EC tissues, and their functions on biological behaviours were examined by a series of in vitro and in vivo assays. Molecule interactions were illustrated by co-transfection assays. The bioinformatics analysis showed that PVT1/miR-612/CENP-H/CDK1 axis played a vital role in the malignant progression of advanced EC. MiR-612 was downregulated in EC tissues and acted as a tumour suppressor to inhibit cell proliferation, migration, invasion, and promote cell apoptosis. CENP-H was found overexpressed in EC tissues, and the expression level was correlated to diagnosis and prognosis of EC. Hyperactivated CENP-H promoted cell proliferation, migration, invasion, and inhibited cell apoptosis. Overexpressed CENP-H prevented the anti-tumour effects observed with upregulated miR-612; knockdown of miR-612 also suppressed the anti-tumour effects of downregulated PVT1. Knockdown of PVT1 together with upregulated miR-612 exerted the strongest anti-tumour effects in nude mice. These effects were mediated by CDK1 through modulation of the Akt/mTOR signaling pathway. In conclusion, the PVT1/miR-612/CENP-H/CDK1 axis promoted the malignant progression of advanced EC and could serve as a promising target for potential treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available